Mirzaten (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine, and by antagonising postsynaptic 5‑HT2 and 5‑HT3 receptors, enhancing serotonergic transmission. The combined effect raises the levels of norepinephrine and serotonin in the brain, contributing to its antidepressant activity.

The exact dose of Mirzaten is determined by the prescribing clinician based on the individual’s clinical condition, response, and tolerability. Physicians typically start with a low dose and may adjust it gradually, but the specific regimen should always follow the prescriber’s instructions.

Safety data for mirtazapine in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers will evaluate the risk‑benefit profile before prescribing it to pregnant or nursing women.

To order Mirzaten, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details and any necessary import documentation.

Compared with selective serotonin reuptake inhibitors (SSRIs), mirtazapine has a distinct mechanism that often results in faster improvement of sleep and appetite. It may cause more sedation and weight gain, whereas SSRIs are generally less sedating but can cause sexual dysfunction. Choice of therapy depends on individual patient needs and side‑effect profiles.

Mirzaten should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources. Do not store in the bathroom or near a kitchen sink. Ensure the container is tightly closed when not in use.

Mirzaten is taken orally, usually once daily in the evening because of its sedative effect. It can be swallowed whole with water and may be taken with or without food, unless the prescriber advises otherwise. Patients should follow the dosing schedule provided by their healthcare professional.

Serious risks include agranulocytosis or severe neutropenia, hepatic dysfunction, seizures, severe hypersensitivity reactions such as Stevens‑Johnson syndrome, and the emergence or worsening of suicidal thoughts, particularly early in treatment. Patients should be monitored closely for any of these events and seek immediate medical attention if they occur.

Mirzaten is contraindicated in patients with known hypersensitivity to mirtazapine or any of its excipients. It should also be avoided in individuals currently taking monoamine oxidase inhibitors (MAOIs) without an appropriate washout period. Caution is advised for patients with severe hepatic impairment, uncontrolled epilepsy, or a history of severe allergic reactions.